“We eventually selected Biofourmis for several reasons, including that the solution helps our patients overcome technology resource obstacles for video encounters and data entry,” Lauren Williams Hopkins, MPH, assistant vice president of virtual care and community engagement at Wellstar MCG Health said. With help from Biofourmis, learn more in mHealthIntelligence about how the Georgia-based health system has improved throughput in the emergency department and inpatient setting, reducing hospital readmissions, enabling optimal clinical outcomes, and improving the experience of patients and their families. https://lnkd.in/g2SHyHUd I #RemotePatientMonitoring #HospitalAtHome #DigitalHealth #VirtualCare #ChronicDiseaseManagement #CareAtHome
Biofourmis
Hospitals and Health Care
Needham, Massachusetts 36,541 followers
Revolutionizing the Delivery of Healthcare.
About us
Biofourmis brings the right care to every person, no matter where they are. The company’s AI-driven solution collects and analyzes over 120 biomarkers in real time and identifies shifts that require proactive interventions. This vital innovation enables Biofourmis to offer people everywhere connected access to hospital-level services, virtual provider networks for remote care, and life-changing clinical trials—all without leaving their homes. Trusted by leading health systems, payers, biopharma companies and patients alike, Biofourmis’ connected platform improves patient outcomes, prevents hospitalization readmissions, accelerates drug development, and closes critical gaps in care—with the goal of making science smarter, healthcare simpler, and patients healthier. Biofourmis is a global technology company enabling care delivery, with headquarters in Boston with key offices in Singapore and India. For more information, visit biofourmis.com and follow Biofourmis on LinkedIn, Twitter and YouTube.
- Website
-
https://www.biofourmis.com/
External link for Biofourmis
- Industry
- Hospitals and Health Care
- Company size
- 201-500 employees
- Headquarters
- Needham, Massachusetts
- Type
- Privately Held
- Founded
- 2015
- Specialties
- Post-acute Monitoring, Artificial Intelligence, Digital Health, Cardiovascular, Digital Therapeutics, Hybrid Clinical Trial, Decentralized Clinical Trials, Remote Patient Management, Oncology, RPM, Pulmonology, Digital Disease Management, Digital Tools, Digital Clinical Trials, Hospital at Home, and Care at Home
Locations
-
Primary
117 Kendrick St
Suite 300
Needham, Massachusetts 02494, US
-
2 Venture Drive
Vision Exchange, #23-01
Singapore, Singapore 608526, SG
-
Kreuzstrausse 2
Zurich, 8008, CH
-
01 - 103, WeWork Prestige Central
36, Infantry Rd
Bengaluru, Karnataka 560001, IN
Employees at Biofourmis
-
Joe Dustin
VP, Product Strategy | BioFourmis | eClinical Tech Executive | Advisor | AI | eCOA | DHTs | Decentralized Trials | Clinical Operations
-
Sean Anderson, MBA
Contracts and Proposals Manager at Biofourmis
-
Justin Davidson
Senior Director of Site Reliability Engineering at Biofourmis
-
Sarah Sossong
Seasoned health system clinical operator & innovator | Deep experience in launching 0-to-1 and scaling to enterprises | Adept in startup scrums and…
Updates
-
By leveraging digital endpoints, clinical trials can be more patient-centric, data-driven, and adaptable to meet the evolving needs of healthcare research. While digital endpoints’ potential is undeniable, widespread adoption remains a challenge. Decision-makers often lack clear value assessments, routine use cases, and efficient deployment strategies around digital endpoints, hindering their numerous benefits. Biofourmis is proud to play a role in Digital Medicine Society (DiMe)’s latest project “Building the Business Case for Digital Endpoints,” which aims to increase investment in digital measurement development and deployment in clinical trials. By developing a value framework, industry benchmarking tools, ROI forecasting models, and a modular template business case framework, our goal is to support innovators across the field to invest in digital endpoints and advance their broad adoption and scale in clinical research. https://lnkd.in/gp4YP2Kt I #DigitalClinicalTrials #DigitalEndpoints #DigitalBiomarkers #DigitalHealth Fierce Healthcare
Digital Medicine Society partners with pharma giants for new digital endpoints project
fiercebiotech.com
-
Patrick McGill, MD MBA, EVP & Chief Transformation Officer, Community Health Network discusses how the organization is leveraging partnerships with innovative companies like Biofourmis to more effectively meet the evolving needs of providers, staff, and consumers. The six-hospital integrated health system recently engaged Biofourmis to help enhance and scale its care-at-home services for patients across the care continuum. With the Biofourmis solution, patients are closely monitored and cared for remotely, with a focus on early interventions to reduce hospital readmissions and emergency department visits. https://lnkd.in/g-6BCwAd I #DigitalHealth #HealthcareInnovation #RemotePatientMonitoring #VirtualCare #CareAtHome healthsystemCIO
“Relentless Pursuit”: How Community Health Network Is Partnering With Startups to Drive Transformation | healthsystemcio.com
https://healthsystemcio.com
-
A big congrats to Orlando Health's Hospital Care at Home program which recently celebrated serving its 1,000th patient. Launched in February 2023, the Central Florida program has seen great success using Biofourmis’ technology, which connects patients to Orlando Health's patient care hub for 24/7 remote monitoring and virtual care by nurses and providers. Our team looks forward to celebrating more program milestones, as we continue to collaborate with the Central Florida health system to meet the evolving needs of the patients they serve. https://lnkd.in/ggv6QKRs I #HospitalAtHome #RemotePatientMonitoring #VirtualCare #DigitalHealth Becker's Healthcare
Orlando Health expands hospital-at-home program
beckershospitalreview.com
-
Biofourmis wishes you and your loved ones a safe and happy Independence Day! 🎇 I #IndependenceDay #FourthOfJuly #LifeAtBiofourmis #BostonBased
-
"Wearable sensor technologies are revolutionizing health research, especially in chronic disease management, by producing real-time health data that can be transformed into digital biomarkers." However, systematic methods for collecting, interpreting, analyzing, and translating this data are lacking. Drawing from the BarKA-MS observational, longitudinal cohort study on physical rehabilitation in individuals with multiple sclerosis (MS), new research presents ten key insights into digital biomarker development. These lessons are intended to guide future research and teaching in utilizing wearable sensor data for digital biomarker development and chronic disease management. https://lnkd.in/gfGhr4J5 I #ChronicDiseaseManagement #DigitalBiomarkers #DigitalHealth Nature Portfolio
From wearable sensor data to digital biomarker development: ten lessons learned and a framework proposal - npj Digital Medicine
nature.com
-
Virtual care has proven to be an effective tool, yielding high patient satisfaction without adverse safety events, according to a study published in JAMA Network Open. Focused on remote radiation oncology care, the study revealed that patients rated virtual care as good or very good, with nearly all avoiding adverse safety events. The remote model significantly reduced travel burdens and costs for patients, with substantial mileage and cost savings reported. Among nearly 3,000 patients surveyed from 2020 to 2022, 98% expressed high satisfaction, and most safety events posed no harm to patients. Researchers emphasized the benefits of remote care, including enhanced access to clinicians, reduced travel, and significant cost savings. These findings suggest that virtual care will continue to play a vital role in chronic care management. https://lnkd.in/grMkeqTZ I #Oncology #RemotePatientMonitoring
Patient safety, satisfaction soar with remote care management | TechTarget
techtarget.com
-
Despite pharma’s emphasis on diversity in clinical trials, many are failing to meet these goals. A recent report from the Office of Inspector General, which reviewed 30 phase 3 trials funded by The National Institutes of Health, revealed that only two-thirds had inclusive enrollment plans. Even among those with such plans, most did not achieve their targets for underrepresented groups. To extend trial participation, many are looking towards scalable, comprehensive decentralized clinical trial solutions that enhance participant engagement and alleviate site burden. By building patient-centric diversified clinical trials, pharma can ensure more representative data, improve the efficacy and safety of treatments across different populations, and ultimately enhance health outcomes for all patients. https://lnkd.in/g-e4gGvM I #DecentralizedClinicalTrials #ClinicalTrialDiversity #DigitalClinicalTrials #HealthEquity PharmaVoice
NIH-funded trials fall flat on diversity goals
pharmavoice.com
-
Digital Health Technologies (DHTs) are increasingly contributing to the economic affordability and environmental sustainability of healthcare systems. By offering customized, adaptable care solutions, they have the potential to facilitate safer and more extensive home-based care while empowering patients to actively engage in their health management. However, substantial national differences exist in how these technologies are perceived, evaluated for regulatory approval, and reimbursed. Researchers are exploring the emerging phenomenon of grouping individual DHTs—each with its own clinical use case and regulatory approval—into packages designed to perform specific clinical tasks in defined settings. https://lnkd.in/ech-f7Hp I #DigitalHealth #RemotePatientMonitoring #VirtualCare #HealthcareInnovation
Digital health technologies need regulation and reimbursement that enable flexible interactions and groupings - npj Digital Medicine
nature.com
-
A new survey from EY’s suggests that digital health technologies are starting to yield strong results for payers. Ernst & Young LLP announced the results of a survey it conducted amongst health insurance executives, revealing that nearly four out of five insurance leaders acknowledge that virtual care has not only bridged the distance between members and providers but has also made care more affordable for members. https://lnkd.in/dx_rWqnC I #DigitalHealth #HealthcareCosts #VirtualCare
New Survey Says Digital Health Care Technology Is Benefitting Payers
pharmexec.com